Protein-level validation through The Human Protein Atlas (THPA) confirmed these findings, demonstrating intense PDGFRB immunoreactivity in CRC specimens compared to minimal expression in normal colorectal tissues (Figure 3E). Here, PDGFRB is linked to colorectal carcinoma.